Applied Therapeutics, Inc. (APLT)

Import this data to Google Sheets with:

=jivedata("APLT","financials")

Full statements spill as a table. For one cell: =jivedata("APLT","Revenue") or =jivedata("APLT","Revenue","TTM"). Install the Jive Data add-on, then paste into a cell.

Applied Therapeutics, Inc.

APLT • CIK 0001697532

(in thousands, except per share data)	FY 2022	FY 2023	FY 2024	TTM
Revenue from Contract with Customer, Excluding Assessed Tax	—	$9,993	$455	$1,000
Operating Expenses	$82,950	$74,528	$104,754	$99,403
Research and Development Expense	$55,634	$53,905	$48,744	$39,056
Operating Income (Loss)	$-82,950	$-64,535	$-104,299	$-98,403
Interest Income (Expense), Nonoperating, Net	$685	$1,372	$3,534	$2,091
Net Income (Loss) Attributable to Parent	$-82,508	$-119,763	$-105,624	$-18,138
Net Income (Loss) Available to Common Stockholders, Basic	$-82,508	$-119,763	—	$-161,089

(in thousands, except per share data)	FY 2022	FY 2023	FY 2024	TTM
Assets	$38,363	$54,833	$86,691	$34,374
Liabilities	$34,302	$71,979	$29,685	$34,935
Assets, Current	$37,308	$54,386	$83,646	$31,654
Cash and Cash Equivalents, at Carrying Value	$16,657	$49,898	$79,398	$11,945
Short-term Investments	$13,923	$13,923	—	$13,923
Other Assets, Current	$674	$100	$461	$255
Operating Lease, Right-of-Use Asset	$857	$447	$2,792	$2,468
Deferred Tax Assets, Net of Valuation Allowance	$272	$139	$870	$870
Liabilities, Current	$33,424	$71,182	$27,296	$32,902
Accounts Payable, Current	$4,534	$1,742	$4,433	$4,800
Liabilities, Noncurrent	$878	$797	$2,389	$2,033
Stockholders' Equity Attributable to Parent	$4,061	$-17,146	$57,006	$-561

(in thousands, except per share data)	FY 2022	FY 2023	FY 2024	TTM
Net Cash Provided by (Used in) Operating Activities	$-78,093	$-55,173	$-84,305	$-86,847
Net Cash Provided by (Used in) Investing Activities	$13,170	$13,872	$13,872	—
Net Cash Provided by (Used in) Financing Activities	$27,692	$74,542	$113,805	$-75

Jive Data

Google Sheets add-onSheets Account

Import this data to Google Sheets with:

=jivedata("APLT","financials")

Full statements spill as a table. For one cell: =jivedata("APLT","Revenue") or =jivedata("APLT","Revenue","TTM"). Install the Jive Data add-on, then paste into a cell.

Applied Therapeutics, Inc.

APLT • CIK 0001697532

(in thousands, except per share data)	FY 2022	FY 2023	FY 2024	TTM
Revenue from Contract with Customer, Excluding Assessed Tax	—	$9,993	$455	$1,000
Operating Expenses	$82,950	$74,528	$104,754	$99,403
Research and Development Expense	$55,634	$53,905	$48,744	$39,056
Operating Income (Loss)	$-82,950	$-64,535	$-104,299	$-98,403
Interest Income (Expense), Nonoperating, Net	$685	$1,372	$3,534	$2,091
Net Income (Loss) Attributable to Parent	$-82,508	$-119,763	$-105,624	$-18,138
Net Income (Loss) Available to Common Stockholders, Basic	$-82,508	$-119,763	—	$-161,089

(in thousands, except per share data)	FY 2022	FY 2023	FY 2024	TTM
Assets	$38,363	$54,833	$86,691	$34,374
Liabilities	$34,302	$71,979	$29,685	$34,935
Assets, Current	$37,308	$54,386	$83,646	$31,654
Cash and Cash Equivalents, at Carrying Value	$16,657	$49,898	$79,398	$11,945
Short-term Investments	$13,923	$13,923	—	$13,923
Other Assets, Current	$674	$100	$461	$255
Operating Lease, Right-of-Use Asset	$857	$447	$2,792	$2,468
Deferred Tax Assets, Net of Valuation Allowance	$272	$139	$870	$870
Liabilities, Current	$33,424	$71,182	$27,296	$32,902
Accounts Payable, Current	$4,534	$1,742	$4,433	$4,800
Liabilities, Noncurrent	$878	$797	$2,389	$2,033
Stockholders' Equity Attributable to Parent	$4,061	$-17,146	$57,006	$-561

(in thousands, except per share data)	FY 2022	FY 2023	FY 2024	TTM
Net Cash Provided by (Used in) Operating Activities	$-78,093	$-55,173	$-84,305	$-86,847
Net Cash Provided by (Used in) Investing Activities	$13,170	$13,872	$13,872	—
Net Cash Provided by (Used in) Financing Activities	$27,692	$74,542	$113,805	$-75

Applied Therapeutics, Inc.

Consolidated Statements of Operations

Consolidated Balance Sheets

Consolidated Statements of Cash Flows

Applied Therapeutics, Inc.

Consolidated Statements of Operations

Consolidated Balance Sheets

Consolidated Statements of Cash Flows